| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Head Of Research &Development | Head Of Research &Development +1 more
1 company
Vig Pamela is a Chief Scientific Officer at Mirum Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 30,559 | $34.00 | $1,039,006.00 | -52.7% | +11.7% | +46.7% | |
| Feb 2, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,214 | $26.19 | $31,796.85 | -4.1% | -3.5% | +84.3% | |
| Jan 8, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Head Of Research &Development | Sell | 1,408 | $28.03 | $39,472.29 | -4.5% | -9.1% | +47.5% | |
| Jul 3, 2023 | MIRM Mirum Pharmaceuticals, Inc. | Head Of Research &Development | Sell | 1,425 | $25.65 | $36,546.41 | -4.4% | +14.2% | +31.3% | |
| Jan 9, 2023 | MIRM Mirum Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,379 | $20.62 | $28,438.15 | -4.8% | +24.7% | +39.4% | |
| Oct 1, 2021 | MIRM Mirum Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,364 | $19.26 | $26,264.91 | -12.4% | -18.8% | +8.6% | |
| Sep 6, 2019 | MIRM Mirum Pharmaceuticals, Inc. | Chief Scientific Officer | Buy | 1,612 | $10.97 | $17,681.76 | +100.8% | - | - |